NDC 68071-5285-01 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-5285
- Requested NDC
- 68071-5285-01
- Package NDCs from labels
- 68071-5285-1, 68071-5285-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-12-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE TABLETS, USP | NuCare Pharmaceuticals,Inc. | 2024-12-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5285-1 | Hydralazine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5285 | HYDRALAZINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20241219_a862321d-ebc1-7676-e053-2995a90a5861.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.